Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
9.8%
% of IXJ's 113 holdings also in IDNA
23.9%
% of IDNA's 51 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
ROCHE HOLDING LTD | 3.2% | 5.5% | 3.2% |
 |
ASTRAZENECA PLC | 3.0% | 5.1% | 3.0% |
 |
MERCK & CO. INC. | 2.9% | 3.9% | 2.9% |
 |
SANOFI-AVENTIS | 1.6% | 5.5% | 1.6% |
|
GSK PLC | 1.1% | 5.3% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to IDNA
|
ELI LILLY & CO | 9.6% |
|
UNITEDHEALTH GROUP INC | 6.0% |
|
JOHNSON & JOHNSON | 5.5% |
|
ABBVIE INC | 4.4% |
|
ABBOTT LABORATORIES | 3.3% |
|
NOVARTIS AG | 3.2% |
 |
NOVO NORDISK A/S-B | 2.9% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
|
AMGEN INC | 2.2% |
IXJ Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.8% |
|
EXELIXIS INC | -5.2% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.5% |
|
GENMAB A/S | -4.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | -4.3% |
|
GSK PLC | -4.3% |
 |
BIONTECH SE SPONSORED ADR | -4.2% |
|
REVOLUTION MEDICINES, INC. | -4.0% |
|
INCYTE CORP | -3.8% |
|
SANOFI-AVENTIS | -3.8% |